154 related articles for article (PubMed ID: 24997647)
21. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
22. Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
Vercellino GF; Piek JM; Schneider A; Köhler C; Mangler M; Speiser D; Chiantera V
Gynecol Oncol; 2012 Sep; 126(3):325-9. PubMed ID: 22704949
[TBL] [Abstract][Full Text] [Related]
23. Pattern of failures and clinical outcome of patients with locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
Gadducci A; Fabrini MG; Perrone F; Manfredi B; Fanucchi A; Laliscia C; Barsotti C; Scotti V; Genazzani AR; Greco C
Anticancer Res; 2010 Sep; 30(9):3731-5. PubMed ID: 20944162
[TBL] [Abstract][Full Text] [Related]
24. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
Zhou XL; Wang M
Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
26. Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?
Ferrandina G; Fanfani F; Ludovisi M; Fagotti A; Carbone A; Zannoni G; Guerriero M; Petrillo M; Scambia G
Gynecol Oncol; 2008 Jan; 108(1):220-5. PubMed ID: 17976708
[TBL] [Abstract][Full Text] [Related]
27. Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial.
Giorda G; Boz G; Gadducci A; Lucia E; De Piero G; De Paoli A; Innocente R; Trovò M; Sorio R; Campagnutta E
Eur J Surg Oncol; 2011 May; 37(5):442-7. PubMed ID: 21492777
[TBL] [Abstract][Full Text] [Related]
28. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
29. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of nuclear factor κ B expression in patients with advanced cervical cancer undergoing radiation therapy followed by hysterectomy.
Baiocchi G; Begnami MD; Fukazawa EM; Oliveira RA; Faloppa CC; Kumagai LY; Badiglian-Filho L; Pellizzon AC; Maia MA; Jacinto AA; Soares FA; Lopes A
J Clin Pathol; 2012 Jul; 65(7):614-8. PubMed ID: 22447917
[TBL] [Abstract][Full Text] [Related]
31. Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma.
Houvenaeghel G; Lelievre L; Buttarelli M; Jacquemier J; Carcopino X; Viens P; Gonzague-Casabianca L
Eur J Surg Oncol; 2007 May; 33(4):498-503. PubMed ID: 17156969
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of survivin, Fas and FasL contributed to cervical cancer development and metastasis.
Wu SF; Zhang JW; Qian WY; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2044-50. PubMed ID: 23280017
[TBL] [Abstract][Full Text] [Related]
33. The role of lymphadenectomy in cervical cancer patients: the significance of the number and the status of lymph nodes removed in 526 cases treated in a single institution.
Ditto A; Martinelli F; Lo Vullo S; Reato C; Solima E; Carcangiu M; Haeusler E; Mariani L; Lorusso D; Raspagliesi F
Ann Surg Oncol; 2013 Nov; 20(12):3948-54. PubMed ID: 23812772
[TBL] [Abstract][Full Text] [Related]
34. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
35. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.
Vallböhmer D; Kuhn E; Warnecke-Eberz U; Brabender J; Hoffmann AC; Metzger R; Baldus SE; Drebber U; Hoelscher AH; Schneider PM
Pharmacogenomics; 2008 Jun; 9(6):681-90. PubMed ID: 18518847
[TBL] [Abstract][Full Text] [Related]
36. Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining.
Skagias L; Politi E; Karameris A; Sambaziotis D; Archondakis A; Ntinis A; Moreas I; Vasou O; Koutselini H; Patsouris E
Anticancer Res; 2009 Oct; 29(10):4163-7. PubMed ID: 19846967
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of survivin in breast cancer: meta-analysis.
Li Y; Ma X; Wu X; Liu X; Liu L
Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
[TBL] [Abstract][Full Text] [Related]
38. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery.
McLellan R; Dillon MB; Woodruff JD; Heatley GJ; Fields AL; Rosenshein NB
Gynecol Oncol; 1994 Feb; 52(2):253-9. PubMed ID: 8314148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
